{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:57Z","timestamp":1786118937187,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/bor.0b013e3282ffdeca","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T05:15:40Z","timestamp":1207199740000},"page":"295-299","source":"Crossref","is-referenced-by-count":38,"title":["Immunization of patients with rheumatoid arthritis with antitumor necrosis factor\u03b1 therapy and methotrexate"],"prefix":"10.1097","volume":"20","author":[{"given":"Hans-Peter","family":"Brezinschek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hofstaetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard F","family":"Leeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Haindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried B","family":"Graninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","first-page":"143","article-title":"The role of bacterial DNA in autoantibody induction","volume":"247","author":"Pisetsky","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338043","article-title":"Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus","volume":"34","author":"Elkayam","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R3-12-20210128","first-page":"1469","article-title":"Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus?","volume":"33","author":"Mercado","year":"2006","journal-title":"J Rheumatol"},{"key":"R4-12-20210128","first-page":"2555","article-title":"Specific antibody response after influenza immunization in systemic lupus erythematosus","volume":"29","author":"Abu-Shakra","year":"2002","journal-title":"J Rheumatol"},{"key":"R5-12-20210128","first-page":"589","article-title":"Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy","volume":"19","author":"Kanakoudi-Tsakalidou","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R7-12-20210128","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R9-12-20210128","first-page":"1203","article-title":"Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity","volume":"21","author":"Chalmers","year":"1994","journal-title":"J Rheumatol"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.vaccine.2006.01.028","article-title":"Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity","volume":"24","author":"Del Porto","year":"2006","journal-title":"Vaccine"},{"key":"R11-12-20210128","first-page":"145","article-title":"Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response","volume":"87","author":"Francioni","year":"1996","journal-title":"Recenti Prog Med"},{"issue":"Suppl 9","key":"R12-12-20210128","first-page":"S40","article-title":"Double blind randomized comparison of a split- and a virosomal influenza vaccine in immunosuppressed rheumatologic patients [abstract]","volume":"56","author":"Seitz","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R13-12-20210128","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC): Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Fiore","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2007.081430","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases","volume":"66","author":"Furst","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R16-12-20210128","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease","year":"2004","journal-title":"J Rheumatol"},{"issue":"Suppl 9","key":"R17-12-20210128","first-page":"1971","article-title":"Pneumococcal vaccination: decreased antibody response in rheumatoid arthritis patients on methotrexate","volume":"9","author":"O'Dell","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R18-12-20210128","first-page":"952","article-title":"Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone","volume":"34","author":"Visvanathan","year":"2007","journal-title":"J Rheumatol"},{"key":"R19-12-20210128","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"R21-12-20210128","first-page":"1238","article-title":"Using vaccine responses to plumb the immunologic consequences of tumour necrosis factor blockade with etanercept","volume":"31","author":"Scheifele","year":"2004","journal-title":"J Rheumatol"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2006.09.027","article-title":"Brief review of the clinical effectiveness of PREVENAR against otitis media","volume":"25","author":"Fletcher","year":"2007","journal-title":"Vaccine"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10198-006-0013-6","article-title":"Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects","volume":"9","author":"Lloyd","year":"2008","journal-title":"Eur J Health Econ"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.vaccine.2007.01.021","article-title":"Prevenar vaccination: review of the global data, 2006","volume":"25","author":"Center","year":"2007","journal-title":"Vaccine"},{"key":"R25-12-20210128","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.61.7.623","article-title":"Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis","volume":"61","author":"Elkayam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.013201","article-title":"Hepatitis B vaccination in children with juvenile idiopathic arthritis","volume":"63","author":"Kasap\u00e7opur","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 9","key":"R28-12-20210128","first-page":"S366","article-title":"Anti-TNF therapy in RA patients alters hepatitis B vaccine responses","volume":"56","author":"Ravikumar","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/506935","article-title":"Antirheumatic drugs and the risk of tuberculosis","volume":"43","author":"Bassard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1191\/096120399678840855","article-title":"Immunization of patients with systemic lupus erythematosus: the current state of play","volume":"8","author":"Ioannou","year":"1999","journal-title":"Lupus"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/rheumatology\/kel104","article-title":"Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy","volume":"45","author":"Fahy","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00393-006-0132-6","article-title":"Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses","volume":"66","author":"Manger","year":"2007","journal-title":"Z Rheumatol"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy","volume":"3","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0889-857X(05)70087-9","article-title":"Vaccination of the immunosuppressed adult patient with rheumatologic disease","volume":"25","author":"Avery","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"R37-12-20210128","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R38-12-20210128","first-page":"162","article-title":"Does methotrexate treatment impair the response to vaccinations in patients with rheumatic diseases?","volume":"4","author":"Hofstaetter","year":"2007","journal-title":"J Mineralstoffwechsel"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282ffdeca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:03Z","timestamp":1786035543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200805000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282ffdeca","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}